Brokerages Set Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Target Price at $8.63

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) have received an average recommendation of “Buy” from the six research firms that are presently covering the firm, Marketbeat reports. Four equities research analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $8.63.

A number of research firms have issued reports on BIOX. Lake Street Capital reduced their price target on Bioceres Crop Solutions from $13.00 to $8.00 and set a “buy” rating on the stock in a research report on Friday, February 7th. Oppenheimer reduced their target price on shares of Bioceres Crop Solutions from $8.00 to $7.00 and set an “outperform” rating on the stock in a report on Tuesday, April 22nd. Finally, Canaccord Genuity Group lowered their price target on shares of Bioceres Crop Solutions from $7.00 to $6.50 and set a “buy” rating for the company in a report on Thursday, February 13th.

Institutional Investors Weigh In On Bioceres Crop Solutions

Several hedge funds and other institutional investors have recently made changes to their positions in BIOX. Jones Financial Companies Lllp boosted its holdings in Bioceres Crop Solutions by 3,535.8% in the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock valued at $25,000 after purchasing an additional 5,339 shares in the last quarter. Bank of America Corp DE boosted its holdings in shares of Bioceres Crop Solutions by 186.8% in the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock valued at $35,000 after buying an additional 3,735 shares in the last quarter. Jump Financial LLC acquired a new position in shares of Bioceres Crop Solutions in the 4th quarter valued at $72,000. Northern Trust Corp purchased a new position in shares of Bioceres Crop Solutions in the 4th quarter valued at $93,000. Finally, Avanza Fonder AB acquired a new stake in Bioceres Crop Solutions during the 1st quarter worth $72,000. Institutional investors and hedge funds own 17.68% of the company’s stock.

Bioceres Crop Solutions Price Performance

Bioceres Crop Solutions stock opened at $4.45 on Monday. The firm has a market cap of $279.06 million, a PE ratio of 222.61 and a beta of 0.40. Bioceres Crop Solutions has a 52-week low of $3.51 and a 52-week high of $11.86. The company has a quick ratio of 0.96, a current ratio of 1.33 and a debt-to-equity ratio of 0.43. The company’s 50 day moving average is $4.35 and its two-hundred day moving average is $5.50.

Bioceres Crop Solutions (NASDAQ:BIOX) last posted its quarterly earnings data on Wednesday, May 21st. The company reported ($0.02) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.10) by $0.08. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.58%. On average, research analysts expect that Bioceres Crop Solutions will post -0.05 EPS for the current fiscal year.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.